GeneWerk

GeneWerk was founded in 2014 by Dr. Christof von Kalle, Dr. Manfred Schmidt, and Dr. Annette Deichmann with the participation of the German Cancer Research Center (DKFZ) in Heidelberg, Germany. GeneWerk is a laboratory specializing in cell and gene therapies, providing preclinical and clinical trial patient sample analysis services. The company is recognized as a leading provider of vector integration site analysis (ISA) services, a method developed by the company's founders that is recommended by the FDA and EMA to be performed after the administration of integrating and non-integrating cell and gene therapies.